The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Immunomic Therapeutics, Inc. - Pioneering the Study of the LAMP-based Nucleic Acid Immunotherapy Platforms

SNNLive spoke with William Hearl, Ph.D., CEO of Immunomic Therapeutics, Inc., a private company, at the BioMaryland Pavilion at the BIO International Convention 2017 in San Diego, CA.

Share With

Wednesday, September 13, 2017

   

© 2017 Stock News Now